Health
Weighing risks and benefits of COVID-19 vaccination in children – Medical Xpress
The U.S. Food and Drug Administration has approved Pfizer’s COVID-19 vaccine for use in children ages five to 11. Pfizer’s clinical…
The U.S. Food and Drug Administration has approved Pfizer’s COVID-19 vaccine for use in children ages five to 11. Pfizer’s clinical trial results indicate the vaccine is safe and effective in this age group.
This is an important development. COVID-19 infectionsare…
Continue Reading
-
General12 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News16 hours agoBrisbane rising on global rankings, but still behind southern capitals
-
Noosa News16 hours agoWest End icon closes doors
-
General19 hours agoCalls for government to ‘get on with’ CSIRO Ginninderra Experiment Station land sale after three-year delay